The Chief Legal Officer of BioXcel Therapeutics has executed a sale of company stock valued at $7,111. This transaction is part of the officer's financial management activities and complies with regulatory requirements. Details regarding the specific number of shares sold or the timing of the sale have not been disclosed. BioXcel Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various medical conditions.
Related Articles
Don't miss out on breaking stories and in-depth articles.